LABT
Lakewood-Amedex Biotherapeutics Inc.
Next earnings ≈ Aug 21, 2026 · est. from filing cadence
$3.47▼ -59.89%
over 1Y
L $0.60Yahoo FinanceH $8.65
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today—
1W-4.9%
1M+375.3%
3M-59.9%
YTD-59.9%
1Y-59.9%
Sell
Conviction
Horizon
Medium (3–12mo)
Mixed signals in the latest filings.
Lakewood-Amedex Biotherapeutics Inc. shows limited reported revenue.
Sources: SEC EDGAR (CIK 0002079272, latest 10-Q filed 2026-05-22) · as of 6/26/2026, 4:02:26 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.